Immunological and Neurometabolite Changes Associated With Switch From Efavirenz to an Integrase Inhibitor.
Asundi A, Robles Y, Starr T, Landay A, Kinslow J, Ladner J, White L, Plank RM, Melbourne K, Weisholtz D, Bennett M, Pan H, Stern E, Lin A, Kuritzkes DR, Lin NH.
Asundi A, et al. Among authors: pan h.
J Acquir Immune Defic Syndr. 2019 Aug 15;81(5):585-593. doi: 10.1097/QAI.0000000000002079.
J Acquir Immune Defic Syndr. 2019.
PMID: 31045650
Free PMC article.